Publications

  1. Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz AN, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner OB, Chandrasekaran S, de St Maurice A, Kanatani M, Curello J, Arias R, Swearingen W, Doernberg SB, Patel R. Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN. Clin Infect Dis. 2021 Jul 1; 73 (1):e39-e46
    View PubMed
  2. McMurry R, Lenehan P, Awasthi S, Silvert E, Puranik A, Pawlowski C, Venkatakrishnan AJ, Anand P, Agarwal V, O'Horo JC, Gores GJ, Williams AW, Badley AD, Halamka J, Virk A, Swift MD, Carlson K, Doddahonnaiah D, Metzger A, Kayal N, Berner G, Ramudu E, Carpenter C, Wagner T, Rajasekharan A, Soundararajan V. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (N Y). 2021 Jul 1 Epub 2021 July 01
    View PubMed
  3. Pawlowski C, Lenehan P, Puranik A, Agarwal V, Venkatakrishnan AJ, Niesen MJM, O'Horo JC, Virk A, Swift MD, Badley AD, Halamka J, Soundararajan V. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med (N Y). 2021 Jun 29 Epub 2021 June 29
    View PubMed
  4. Pawlowski C, Roncon-Hekking J, Awasthi S, Pandey V, Lenehan P, Venkatakrishnan AJ, Bade S, O'Horo JC, Virk A, Swift MD, Williams AW, Gores GJ, Badley AD, Halamka J, Soundararajan V. Cerebral venous sinus thrombosis (CVST) is not significantly linked to COVID vaccines or non-COVID vaccines in a large multi-state US health system Journal of Stroke and Cerebrovascular Diseases. 2021.
  5. Pritchett JC, Borah BJ, Desai AP, Xie Z, Saliba AN, Leventakos K, Coffey JD, Pearson KK, Speicher LL, Orenstein R, Virk A, Ganesh R, Paludo J, Halfdanarson TR, Haddad TC. Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO Oncol Pract. 2021 Jun 4; OP2100307 Epub 2021 June 04
    View PubMed
  6. Swift MD, Breeher LE, Tande AJ, Tommaso CP, Hainy CM, Chu H, Murad MH, Berbari EF, Virk A. Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel. Clin Infect Dis. 2021 Apr 26 [Epub ahead of print]
    View PubMed
  7. Tande AJ, Pollock BD, Shah ND, Farrugia G, Virk A, Swift M, Breeher L, Binnicker M, Berbari EF. Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening. Clin Infect Dis. 2021 Mar 10 [Epub ahead of print]
    View PubMed
  8. Finney Rutten LJ, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, St Sauver JL, Virk A, Jacobson RM. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clin Proc. 2021 Mar; 96 (3):699-707 Epub 2020 Dec 30
    View PubMed
  9. Vollmer NJ, Rivera CG, Stevens RW, Oravec CP, Mara KC, Suh GA, Osmon DR, Beam EN, Abdel MP, Virk A. Safety and Tolerability of Fluoroquinolones in Patients with Staphylococcal Periprosthetic Joint Infections. Clin Infect Dis. 2021 Feb 19 [Epub ahead of print]
    View PubMed
  10. Swift Melanie D. , MD, MPH, Sampathkumar Priya , MD,, Breeher Laura E. , MD, MPH, Ting Henry H. , MD, MBA, Virk Abinash , MD, DTM&H. Mayo Clinic’s Multidisciplinary Approach to Covid-19 Vaccine Allocation and Distribution NEJM Catalyst. 2021.
  11. Jansson-Knodell CL, Harris CE, Loftus EV Jr, Walker RC, Enzler MJ, Virk A. Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics? Dig Dis Sci. 2021 Jan; 66 (1):190-198 Epub 2020 Mar 07
    View PubMed
  12. Finney Rutten LJ, Zhu X, Leppin A, Ridgeway JL, Swift M, Griffin JM, St Sauver JL, Virk A, Jacobson RM. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy Mayo Clinic Proceedings. 2020.
  13. Suh GA, Shah AS, Kasten MJ, Virk A, Domonoske CL, Razonable RR. Avoiding a Medical Education Quarantine During the Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S63-S65 Epub 2020 June 20
    View PubMed
  14. Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc. 2020 Jul; 95 (7):1467-1481 Epub 2020 May 30
    View PubMed
  15. Shafiyi A, Anavekar NS, Virk A, Sohail MR, Lahr BD, DeSimone DC, Wilson WR, Baddour LM. Repeat transesophageal echocardiography in infective endocarditis: An analysis of contemporary utilization. Echocardiography. 2020 Jun; 37 (6):891-899 Epub 2020 May 16
    View PubMed
  16. Virk A, Schutte KM, Steckelberg JM, Wilson WR, Sinak LJ, Baddour LM. End-of-Therapy Echocardiography May Not Be Needed in All in Patients With Endocarditis. Open Forum Infect Dis. 2020 Mar; 7 (3):ofaa069 Epub 2020 Feb 28
    View PubMed
  17. Virk A, Jayawant M, Springer DJ, Kasten MJ. Electronic consultations with Video Supported PowerPoint versus in-clinic face-to-face, pre-travel consultations: A single-centre, comparative analysis. Travel Med Infect Dis. 2020 Jan - Feb; 33:101556 Epub 2020 Jan 11
    View PubMed
  18. Tai DBG, Graffeo CS, Kotsenas A, Meyer FB, Virk A. Disseminated tuberculosis confounding a co-morbid primary CNS lymphoma. IDCases. 2020; 22:e00965 Epub 2020 Sept 22
    View PubMed
  19. Valencia JCB, Abdel MP, Virk A, Osmon DR, Razonable RR. Destination Joint Spacers, Reinfection, and Antimicrobial Suppression. Clin Infect Dis. 2019 Aug 30; 69 (6):1056-1059
    View PubMed
  20. Narayanan P, Knoph K, Chen N, McCoy C, Devalapalli A, Schoonover K, Schuetz AN, Estes L, Polley E, Kashiwagi D, Virk A. Decreasing Treatment of Asymptomatic Bacteriuria: An Interprofessional Approach to Antibiotic Stewardship. Journal of Clinical Outcomes Managment. 2019; 26(4):169-174.
  21. Harris CE, Jansson-Knodell CL, Virk A. 69-Year-Old Woman With Fevers, Diarrhea, and Abdominal Pain. Mayo Clin Proc. 2019 May; 94 (5):e61-e66 Epub 2019 Feb 10
    View PubMed
  22. Bezalel SA, Onajin O, Gonzalez-Santiago TM, Patel R, Pritt BS, Virk A, Gibson LE, Peters MS. Leprosy in a Midwestern Dermatology Clinic: Report of 9 Patients. Mayo Clin Proc. 2019 Mar; 94 (3):417-423 Epub 2019 Feb 21
    View PubMed
  23. Tan EM, Marcelin JR, Virk A. Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infect Dis Health. 2019 Feb; 24 (1):13-22 Epub 2018 Oct 26
    View PubMed
  24. Johnson KR, Schupack DA, Virk A. 31-Year-Old South African Man With Fever and Headache. Mayo Clin Proc. 2019 Feb; 94 (2):336-340 Epub 2019 Jan 10
    View PubMed
  25. Chen CJ, Virk A. 57-Year-Old Woman With Fever and Confusion. Mayo Clin Proc. 2019 Jan; 94 (1):145-148 Epub 2018 Nov 28
    View PubMed
  26. Ramanan P, Virk A, Boland JM, Pritt B, Rizzo M, Wengenack NL. Photo Quiz: It's a Concrete Jungle Out There. J Clin Microbiol. 2018 Aug; 56 (8) Epub 2018 July 26
    View PubMed
  27. Ramanan P, Virk A, Boland JM, Pritt B, Rizzo M, Wengenack NL. Answer to August 2018 Photo Quiz. J Clin Microbiol. 2018 Aug; 56 (8) Epub 2018 July 26
    View PubMed
  28. Crews NR, Cawcutt KA, Pritt BS, Patel R, Virk A. Diagnostic Approach for Classic Compared With Localized Whipple Disease. Open Forum Infect Dis. 2018 Jul; 5 (7):ofy136 Epub 2018 June 13
    View PubMed
  29. Knoph KN, Narayanan PP, Chen X, McCoy CP, Devalapalli AP, Schoonover KL, Kashiwagi DT, Schuetz A, Estes LL, Polley E, Virk A. Impact of Information Technology and Educational Interventions to Decrease Inappropriate Urine Culture Ordering and Inappropriate Treatment of Asymptomatic Bacteriuria (Pending). 2018.
  30. Whitaker JA, Poland CM, Beckman TJ, Bundrick JB, Chaudhry R, Grill DE, Halvorsen AJ, Huber JM, Kasten MJ, Mauck KF, Mehta RA, Olson T, Thomas KG, Thomas MR, Virk A, Wingo MT, Poland GA. Immunization education for internal medicine residents: A cluster-randomized controlled trial. Vaccine. 2018 Mar 27; 36 (14):1823-1829 Epub 2018 Feb 26
    View PubMed
  31. Virk A, Pritt B, Patel R, Uhl JR, Bezalel SA, Gibson LE, Stryjewska BM, Peters MS. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerg Infect Dis. 2017 Nov; 23 (11):1864-1866
    View PubMed
  32. Tan EM, Nagpal A, DeSimone DC, Anderson B, Linderbaum J, De Ziel T, Li Z, Sohail MR, Cha YM, Loomis E, Espinosa R, Friedman PA, Greason K, Schiller H, Virk A, Wilson WR, Steckelberg JM, Baddour LM. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50 (1):117-124 Epub 2017 Aug 26
    View PubMed
  33. Virk A, Mahmood M, Kalra M, Bower TC, Osmon DR, Berbari EF, Raoult D. Coxiella burnetii multilevel disk space infection, epidural abscess, and vertebral osteomyelitis secondary to contiguous spread from infected abdominal aortic aneurysm or graft: report of 4 cases acquired in the US and review of the literature Open Forum Infectious Diseases. 2017 Fal; 4(4):ofx192. Epub 1900 Jan 01.
  34. Virk A, Mahmood M, Kalra M, Bower TC, Osmon DR, Berbari EF, Raoult D. Coxiella burnetii Multilevel Disk Space Infection, Epidural Abscess, and Vertebral Osteomyelitis Secondary to Contiguous Spread From Infected Abdominal Aortic Aneurysm or Graft: Report of 4 Cases Acquired in the US and Review of the Literature. Open Forum Infect Dis. 2017 Fall; 4 (4):ofx192 Epub 2017 Sept 12
    View PubMed
  35. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, Virk A. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 1; 64 (11):1516-1521
    View PubMed
  36. Frazee E, Rule AD, Lieske JC, Kashani KB, Barreto JN, Virk A, Kuper PJ, Dierkhising RA, Leung N. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project. Am J Kidney Dis. 2017 May; 69: (5)658-666.
    View PubMed
  37. Tyner HL, Virk A, Nassr A, Razonable R. Mycoplasma hominis vertebral spine infection: Case report and a review of infections of bone and joints. J Infect Chemother. 2016 Nov; 22: (11)755-758.
    View PubMed
  38. Mushtaq A, Greenwood-Quaintance KE, Cole NC, Kohner PC, Ihde SM, Strand GJ, Harper LW, Virk A, Patel R. Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. Antimicrob Agents Chemother. 2016 Aug; 60 (8):5036-9 Epub 2016 July 22
    View PubMed
  39. Tan EM, Marcelin JR, Mason E, Virk A. Mycobacterium avium intracellulare complex causing olecranon bursitis and prosthetic joint infection in an immunocompromised host. J Clin Tuberc Other Mycobact Dis. 2016 Jan; 2:1-4 Epub 2015 Dec 03
    View PubMed
  40. Tan E, Marcelin JR, Virk A. 44-Year-Old Man With Left-Sided Paresthesias and Homonymous Hemianopsia. Mayo Clin Proc. 2015 Sep; 90: (9)1278-82.
    View PubMed
  41. Greenwood-Quaintance KE, Kohner P, Osmon DR, Virk A, Patel R. Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection. Diagn Microbiol Infect Dis. 2015 Jun; 82: (2)177-8.
    View PubMed
  42. Gupta A, Berbari EF, Osmon DR, Virk A. Prosthetic joint infection due to Salmonella species: a case series. BMC Infect Dis. 2014 Nov 26; 14:633
    View PubMed
  43. Gomez E, Kennedy CC, Gottschalk M, Cunningham SA, Patel R, Virk A. Streptococcus suis-related prosthetic joint infection and streptococcal toxic shock-like syndrome in a pig farmer in the United States. J Clin Microbiol. 2014 Jun; 52 (6):2254-8 Epub 2014 Apr 09
    View PubMed
  44. Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, Voskoboev N, Lieske JC. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: A cohort study. Crit. Care. 2014; 18(3):R110.
    View PubMed
  45. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20(2):88-94. Epub 2013 Jan 25.
    View PubMed
  46. Agyemang EA, Virk A. 57-Year-old man with fever, rash, chronic watery diarrhea, cough, and sweats. Mayo Clin Proc. 2012 Nov; 87(11):e83-6.
    View PubMed
  47. Alasmari FA, Tleyjeh IM, Riaz M, Greason KL, Berbari EF, Virk A, Baddour LM. Temporal trends in the incidence of surgical site infections in patients undergoing coronary artery bypass graft surgery: a population-based cohort study, 1993 to 2008. Mayo Clin Proc. 2012 Nov; 87 (11):1054-61
    View PubMed
  48. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29 (8):961-7 Epub 2010 May 27
    View PubMed
  49. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16.
    View PubMed
  50. Tsigrelis C, Tleyjeh IM, Huskins WC, Lahr BD, Nyre LM, Virk A, Baddour LM. Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2009 Oct; 84(10):871-5.
    View PubMed
  51. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota. J Infect. 2009 Sep; 59 (3):188-93 Epub 2009 July 14
    View PubMed
  52. Reyburn AM, Virk A. 22-year-old woman with fever and jaundice after travel to Ghana. Mayo Clin Proc. 2009 May; 84 (5):461-4
    View PubMed
  53. Sohail MR, Gray AL, Baddour LM, Tleyjeh IM, Virk A. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94. Epub 2009 Mar 02.
    View PubMed
  54. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis. 2008 Dec 1; 47 (11):1367-71
    View PubMed
  55. Anastassiades CP, Virk A. From gut to bone. Am J Med. 2008 Sep; 121(9):767-9.
    View PubMed
  56. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008 Aug 15; 86(3):407-12.
    View PubMed
  57. Lassmann B, Tsigrelis C, Virk A. 33-year-old woman with marked eosinophilia. Mayo Clin Proc. 2007 Jan; 82(1):103-6.
    View PubMed
  58. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006 Oct; 142(10):1287-92.
    View PubMed
  59. Tleyjeh IM, Georgescu G, Virk A, Barajas ED, Mirzoyev Z, Anavekar N, Baddour LM. Cytomegalovirus cholangitis presenting with recurrent hemobilia. Eur J Clin Microbiol Infect Dis. 2005 Sep; 24 (9):634-6
    View PubMed
  60. Virk A, Fischer PR. Travel medicine: an American view of the Australian perspective. Travel Med Infect Dis. 2005 May; 3 (2):77-9
    View PubMed
  61. Uslan DZ, Virk A. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers. J Travel Med. 2005 Jan-Feb; 12 (1):14-8
    View PubMed
  62. Virk A, Fischer PR. Travel medicine: An American view of the Australian perspective. Travel Medicine & Infectious Disease. 2005; 3(2):77-9.
  63. Meehan AM, Virk A, Swanson K, Poeschla EM. Severe pleuropulmonary paragonimiasis 8 years after emigration from a region of endemicity. Clin Infect Dis. 2002 Jul 01; 35: (1)87-90.
    View PubMed
  64. Virk A. Medical advice for international travelers. Mayo Clin Proc. 2001 Aug; 76(8):831-40.
    View PubMed
  65. Virk A, Osmon DR. Prosthetic joint infection: Current treatment ooptions. Current Treatment Options in Infectious Diseases. 2001; 3(4):287-301.
  66. Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clin Proc. 2000 Feb; 75(2):200-14.
    View PubMed
  67. Fischer PR, Virk A. Travel Advisory. In: Primary Care Reports. 1999.